The National Cardiothoracic Centre (NCTC) of the Korle Bu Teaching Hospital has performed Ghana’s first minimally invasive pulmonary valve replacement, opening a new chapter in the treatment of complex heart conditions locally.
The procedure, known as Transcatheter Pulmonary Valve Replacement (TPVR), was performed on a 14-year-old girl with severe pulmonary valve regurgitation, using an advanced Harmony Valve designed for patients with enlarged pulmonary arteries.
Unlike conventional open-heart surgery, the procedure does not require the chest to be opened. Instead, doctors inserted the valve through a blood vessel in the patient’s thigh and guided it to the heart, where it was positioned to restore normal valve function.
The intervention took approximately one hour, with post-procedure assessments indicating that the implanted valve was functioning well and the patient was recovering.
The milestone was achieved through a collaboration between the NCTC, Germany-based Kinderherzen International and the Gerald Asamoah Foundation as part of their annual medical partnership.
The team leader for the two international partners, Dr Katja Pauli, highlighted the importance of early diagnosis and timely treatment of heart conditions, noting that pulmonary valve insufficiency could occur even in the absence of other heart diseases.
She stressed the need for proper medical assessment and regular monitoring, adding that some heart conditions could be detected during pregnancy, making early screening important for better treatment outcomes.
NCTC Director, Dr Kow Entsua-Mensah, described the procedure as a significant advancement in the Centre’s efforts to bring specialised cardiac treatment closer to Ghanaians.
He said the Harmony Valve represented an important development in transcatheter pulmonary valve technology and expressed pride that Ghana had joined the group of countries capable of performing the specialised intervention.
Dr Entsua-Mensah said the partnership had also enabled several babies and children with congenital heart conditions to benefit from critical cardiac catheterisation procedures and surgeries using the Centre’s newly installed Catheterisation Laboratory.

Further interventions planned under the collaboration include Patent Ductus Arteriosus (PDA) closure, which seals an abnormal connection between two major blood vessels near the heart, and Atrial Septal Defect (ASD) closure, which repairs an opening between the heart’s upper chambers.
Parents of some beneficiaries welcomed the interventions, describing them as a source of hope and relief for families who might otherwise struggle to access highly specialised treatment.
They expressed gratitude to the medical teams and partners, particularly for making life-saving procedures available to their children at no cost through the support of the NCTC, its international partners and the Ghana Medical Trust Fund.
The breakthrough strengthens Ghana’s capacity to manage complex cardiac conditions locally, potentially reducing the need for patients to travel abroad for specialised treatment.
Source: www.kumasimail.com
































































